We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.07B
AUM Growth
-$11.6M
Cap. Flow
-$144M
Cap. Flow %
-2.83%
Top 10 Hldgs %
24.83%
Holding
159
New
22
Increased
53
Reduced
27
Closed
17

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$48.3M
2
FLYW icon
Flywire
FLYW
+$47.9M
3
DLO icon
dLocal
DLO
+$36.1M
4
DV icon
DoubleVerify
DV
+$35.7M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$31.3M

Top Sells

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$108M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$106M
3
BHVN icon
Biohaven
BHVN
+$74.9M
4
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
+$68M
5
MDB icon
MongoDB
MDB
+$57.4M

Sector Composition

Rank Sector Weight
1 Healthcare 43.02%
2 Technology 23.53%
3 Industrials 12.87%
4 Consumer Discretionary 5.44%
5 Utilities 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVT icon
51
nVent Electric
NVT
$23.4B
$32.5M 0.64%
845,056
-28,244
-3% -$1.04M
BEP icon
52
Brookfield Renewable
BEP
$9.9B
$31.3M 0.62%
1,236,000
– –
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
$31.2M 0.61%
+242,545
New +$31.3M
VRSK icon
54
Verisk Analytics
VRSK
$26.1B
$30.4M 0.6%
172,193
+14,393
+9% +$2.53M
COGT icon
55
Cogent Biosciences
COGT
$7.07B
$29.9M 0.59%
2,589,778
-271,114
-9% -$3.36M
RPRX icon
56
Royalty Pharma
RPRX
$26.2B
$29.6M 0.58%
+748,423
New +$31.2M
VECT
57
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$29.3M 0.58%
3,405,644
+1,066,600
+46% +$8.59M
NDAQ icon
58
Nasdaq
NDAQ
$53.2B
$28.9M 0.57%
471,583
+34,358
+8% +$2.14M
BILL icon
59
BILL Holdings
BILL
$4.52B
$28.9M 0.57%
265,310
+252,810
+2,022% +$30.4M
CDW icon
60
CDW
CDW
$18.6B
$27.7M 0.55%
155,167
+12,467
+9% +$2.19M
INSP icon
61
Inspire Medical Systems
INSP
$1.44B
$27.3M 0.54%
108,220
+24,170
+29% +$5.15M
PRTA icon
62
Prothena Corp
PRTA
$440M
$26.4M 0.52%
438,732
+208,732
+91% +$12.2M
STE icon
63
Steris
STE
$22.5B
$25.8M 0.51%
139,445
+93
+0.1% +$16.4K
CYTK icon
64
Cytokinetics
CYTK
$10.9B
$25.5M 0.5%
+556,000
New +$23.9M
XENE icon
65
Xenon Pharmaceuticals
XENE
$6.2B
$25.3M 0.5%
641,200
– –
BCYC
66
Bicycle Therapeutics
BCYC
$280M
$25.3M 0.5%
853,800
– –
WMB icon
67
Williams Companies
WMB
$86.7B
$25.1M 0.5%
762,939
+10,039
+1% +$327K
HASI icon
68
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$23.8M 0.47%
822,664
– –
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$11.7B
$23.8M 0.47%
+230,000
New +$21.6M
AURA icon
70
Aura Biosciences
AURA
$735M
$23.6M 0.47%
+2,251,368
New +$28.7M
PRVA icon
71
Privia Health
PRVA
$3.01B
$22.7M 0.45%
1,000,000
+584,015
+140% +$16.3M
IRTC icon
72
iRhythm Holdings
IRTC
$3.91B
$22.4M 0.44%
239,135
+90,305
+61% +$9.83M
NARI
73
DELISTED
Inari Medical, Inc. Common Stock
NARI
$22.2M 0.44%
349,711
+83,681
+31% +$6.07M
BEPC icon
74
Brookfield Renewable
BEPC
$6.04B
$21.3M 0.42%
775,019
– –
SNPS icon
75
Synopsys
SNPS
$71.3B
$20.6M 0.41%
64,371
+12,205
+23% +$3.82M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Eventide Asset Management held 159 positions worth $5.07B, down 0.23% from $5.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q4 2022 filing shows 22 new, 53 increased, 27 reduced and 17 closed positions. Its largest new stake was Seagen Inc. Common Stock: 242,545 shares worth $31.2M. The largest sale was Cintas, an estimated $108M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2022 buy was Seagen Inc. Common Stock: 242,545 shares worth $31.2M.
  • Eventide Asset Management added most to Evolent Health in Q4 2022, an estimated $48.3M increase.
  • Eventide Asset Management's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $106M.
  • Eventide Asset Management fully exited Cintas in Q4 2022, selling an estimated $108M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.07B portfolio in Q4 2022.
  • Eventide Asset Management opened 22 new positions and closed 17 in Q4 2022.
  • Eventide Asset Management's portfolio value fell 0.23% quarter-over-quarter to $5.07B.

Based on Eventide Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.